Here, this study demonstrated that combination of the PI3Kβ inhibitor AZD6482 and the MLK3 inhibitor URMC-099 showed synergistic inhibitory effects on the proliferation, migration and invasion of GBM cells U-87 MG and U-118 MG. The gene discussed is MAP3K11; the disease is glioblastoma.